SK Biopharmaceuticals Co., Ltd. (KRX:326030)
South Korea · Delayed Price · Currency is KRW 124,100
-700 (-0.56%)
Jan 9, 2026, 10:20 AM KST
SK Biopharmaceuticals Market Cap
SK Biopharmaceuticals has a market cap or net worth of 9.77 trillion as of January 8, 2026. Its market cap has increased by 28.79% in one year.
Market Cap
9.77T
Enterprise Value
9.58T
Revenue
675.41B
Ranking
n/a
PE Ratio
30.50
Stock Price
124,100.00
Market Cap Chart
Since July 2, 2020, SK Biopharmaceuticals's market cap has decreased from 9.95T to 9.77T, a decrease of -1.73%. That is a compound annual growth rate of -0.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 8, 2026 | 9.77T | 0.16% |
| Dec 30, 2025 | 9.76T | 12.15% |
| Dec 30, 2024 | 8.70T | 10.66% |
| Dec 28, 2023 | 7.86T | 39.25% |
| Dec 29, 2022 | 5.65T | -25.82% |
| Dec 30, 2021 | 7.61T | -42.49% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 2, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 79.30T |
| Celltrion | 46.60T |
| ALTEOGEN | 25.35T |
| ABL Bio | 11.08T |
| Yuhan | 8.55T |
| HLB Co., Ltd. | 7.09T |
| LigaChem Biosciences | 6.38T |
| Hanmi Pharm. | 5.95T |